why choose us

First received: May 08, 2023

Clinical Trial: Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Migraine

Study Type: INTERVENTIONAL


Official Title: A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study With An Active Treatment Extension to Evaluate the Efficacy, Safety, and Tolerability of Oral Atogepan

Brief Summary: A migraine is a moderate to severe headache on one side of the head.A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms.This study will assess how safe and effective three different doses of atogepant is compared to placebo in adult Japanese participants.Change in migraine symptoms will be assessed.Atogepant (Qulipta) is an approved drug to treat adults with episodic migraine in the United States.Participants are randomly…

Read more